Dagco, Inc. Bristol Myers Squibb CO Transaction History

Dagco, Inc.

$243 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $142,020 - $161,024	2,960 Added 501.69%	3,550 $192,000
Q4 2023 Feb 15, 2024	SELL	$48.48 - $57.85 $624,083 - $744,703	-12,873 Reduced 95.62%	590 $30,000
Q3 2023 Dec 07, 2023	BUY	$57.89 - $64.73 $490,444 - $548,392	8,472 Added 169.75%	13,463 $781,000
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $34,721 - $38,553	-545 Reduced 9.84%	4,991 $319,000
Q1 2023 May 05, 2023	BUY	$65.71 - $74.53 $394 - $447	6 Added 0.11%	5,536 $383,000
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $9,929 - $11,758	-145 Reduced 2.56%	5,530 $397,000
Q3 2022 Nov 01, 2022	SELL	$0.13 - $76.84 $44 - $26,586	-346 Reduced 5.75%	5,675 $403,000
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $363 - $399	5 Added 0.08%	6,021 $464,000
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $8,853 - $10,615	-144 Reduced 2.34%	6,016 $460,000
Q4 2021 Jan 24, 2022	SELL	$53.63 - $62.52 $23,865 - $27,821	-445 Reduced 6.74%	6,160 $384,000
Q3 2021 Nov 01, 2021	SELL	$59.17 - $69.31 $8,520 - $9,980	-144 Reduced 2.13%	6,605 $391,000
Q2 2021 Jul 12, 2021	SELL	$61.91 - $67.42 $25,940 - $28,248	-419 Reduced 5.85%	6,749 $451,000
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $17,445 - $19,621	-294 Reduced 3.94%	7,168 $453,000
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $12,645 - $14,329	-219 Reduced 2.85%	7,462 $463,000
Q3 2020 Oct 19, 2020	SELL	$57.43 - $63.64 $5,398 - $5,982	-94 Reduced 1.21%	7,681 $463,000
Q2 2020 Jul 27, 2020	SELL	$54.82 - $64.09 $7,894 - $9,228	-144 Reduced 1.82%	7,775 $457,000
Q1 2020 Apr 30, 2020	SELL	$46.4 - $67.43 $5,568 - $8,091	-120 Reduced 1.49%	7,919 $441,000
Q4 2019 Feb 06, 2020	SELL	$49.21 - $64.19 $9,546 - $12,452	-194 Reduced 2.36%	8,039 $516,000
Q3 2019 Oct 28, 2019	SELL	$42.77 - $50.71 $13,643 - $16,176	-319 Reduced 3.73%	8,233 $418,000
Q2 2019 Aug 08, 2019	SELL	$44.62 - $49.34 $6,380 - $7,055	-143 Reduced 1.64%	8,552 $388,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $26,801 - $31,957	-594 Reduced 6.39%	8,695 $415,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $452,931 - $587,343	9,289 New	9,289 $483,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dagco, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dagco, Inc. with notifications on news.

Account